Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields.
 
We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. 
 
We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. 

Our expertise:

 › Alzheimer’s disease (AD)
 › Parkinson’s disease (PD) 
› Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease)
 › Multiple Sclerosis (MS)
 › Peripheral Neuropathies 
 › Blood Brain Barrier

DRUG DEVELOPMENT SERVICES 

Our experts in drug and pharmaceutical development provide expert guidance on: 
•The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models)
•The design of your preclinical research programs (in vitro/ in vivo, mode of action)
•The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies)
•The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication

Life Sciences

Pharmaceutical

Research

Therapeutics

NEURO-SYS

NEURO-SYS' headquarters in Gardanne, France

Description

People (2)

Yann Jaudouin

Caroline le Duigou

Jobs